Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults.
Sponsor: University Hospital, Bordeaux
Summary
The analgesic treatment for vaso-occlusive crisis (VOC) in sickle-cell patients is an emergency. The reference treatment is morphine, which requires a venous way sometimes difficult to obtain in these patients. Sufentanil intranasal has been shown to be effective in traumatology. The objective is to evaluate, in VOC, the efficacy of intranasal sufentanil relayed by morphine IV compared to the usual protocol, Equimolar Mixture of Oxygen-Nitrous Oxide (EMONO) relayed by morphine intravenous (IV).
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
115
Start Date
2021-07-20
Completion Date
2024-07-21
Last Updated
2026-06-22
Healthy Volunteers
No
Conditions
Interventions
Sufentanil
The intervention is intranasal Sufentanil adminstration, then IV morphine as soon as possible.
EMONO
In the control group, patients will receive EMONO then IV morphine as soon as possible.
Locations (8)
Hopital Pellegrin
Bordeaux, France
Hôpital Louis Mourier
Colombes, France
Gonesse Hospital
Gonesse, France
Hôpital Edouard Herriot
Lyon, France
Hôpital Charles Nicolle
Rouen, France
Hôpital Rangueil
Toulouse, France
CH de Cayenne
Cayenne, French Guiana
CHU Pointe à Pitre
Les Abymes, Guadeloupe